Surgical approach to patients with low-burden stage III melanoma: Is it time to consider conservative surgery?

Eur J Surg Oncol. 2020 Apr;46(4 Pt A):498-500. doi: 10.1016/j.ejso.2019.11.500. Epub 2019 Nov 16.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Chemotherapy, Adjuvant
  • Disease-Free Survival
  • Humans
  • Imidazoles / therapeutic use
  • Lymph Node Excision / methods*
  • Melanoma / drug therapy
  • Melanoma / pathology
  • Melanoma / surgery*
  • Molecular Targeted Therapy
  • Neoadjuvant Therapy
  • Neoplasm Staging
  • Oximes / therapeutic use
  • Protein Kinase Inhibitors / therapeutic use
  • Proto-Oncogene Proteins B-raf / antagonists & inhibitors
  • Pyridones / therapeutic use
  • Pyrimidinones / therapeutic use
  • Sentinel Lymph Node / pathology*
  • Sentinel Lymph Node Biopsy / methods
  • Skin Neoplasms / drug therapy
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery*
  • Survival Rate
  • Tumor Burden

Substances

  • Imidazoles
  • Oximes
  • Protein Kinase Inhibitors
  • Pyridones
  • Pyrimidinones
  • trametinib
  • Proto-Oncogene Proteins B-raf
  • dabrafenib